Pharmaceutical firm ScieGen is expanding its manufacturing operations on Long Island and adding over 100 jobs.
The $15 million expansion will help ScieGen, a subsidiary of Bactolac Pharmaceutical, bolster its production of prescription drugs to meet growing demands.
The company plans to convert 65,000 s/f of former warehouse space at its facility at 33 Oser Avenue in Hauppauge into manufacturing space with washrooms, an office, labs and a cafeteria.
And it will use Long Island-based vendors to make the space FDA compliant.
“We’re excited to continue to grow on Long Island and develop a much-needed production space for pharmaceutical manufacturing,” said Bactolac Pharmaceutical Inc.’s, Chief Financial Officer Renee Reynolds. “The Suffolk IDA continues to be an active partner in our growth, and their assistance will greatly help us continue to employ hundreds of Long Islanders and produce essential medications.”
Suffolk County Industrial Development Agency (IDA) has preliminarily approved a transaction to assist ScieGen convert and renovate the Oser Avenue space/. The IDA has supported the pharma firm since it first opened in Hauppauge in 2009, producing generic prescription drugs and medications. The company has expanded to multiple locations since. Parent company Bactolac, which makes vitamins and dietary supplements, was established in 1995 and has grown from a single, 5,000 s/f facility in Westbury to multiple facilities across Long Island.
The two companies combine for over 700 employees and generated dozens of jobs bringing their facilities up to code and FDA-compliant. In the last three years alone, they have expended over $121 million to local vendors and contractors and they aim to utilize Long Island-based vendors and contractors throughout this latest project.
“At a time when so many are losing their jobs and businesses are struggling to keep the doors open, we are fortunate to have a solid company, rooted right here in Suffolk County, ready to make a sizable investment that will create more than 100 jobs,” said Tony Catapano, Executive Director of the Suffolk County IDA.
“During the height of a public health and economic crisis, the Suffolk IDA is pleased to assist ScieGen expand their capacity for manufacturing pharmaceuticals while also creating opportunities for our residents.”
“A continued partnership with ScieGen is a win for Long Island and its pharmaceutical manufacturing industry, especially during these incredibly challenging times,” said Kelly Morris, Deputy Executive Director of the Suffolk County IDA. “The companies employ hundreds of Long Island residents and provide millions in tax revenue for the region and we are proud that they call Suffolk County home.”